Company profile for Nykode Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Nykode Therapeutics is an Oslo-based clinical-stage biopharmaceutical platform company founded in 2007. Our bold aim is to generate game-changing therapeutics to treat cancers and infectious diseases with a high unmet medical need. With our unique and innovative modular vaccine technology, we’re specifically targeting antigens to Antigen Presenting Cells, which are essential for inducing rapid, strong and long-lasting immune...
Nykode Therapeutics is an Oslo-based clinical-stage biopharmaceutical platform company founded in 2007. Our bold aim is to generate game-changing therapeutics to treat cancers and infectious diseases with a high unmet medical need. With our unique and innovative modular vaccine technology, we’re specifically targeting antigens to Antigen Presenting Cells, which are essential for inducing rapid, strong and long-lasting immune responses.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Norway
Address
Address
Oslo Research Park Gaustadalléen 21 0349 Oslo
Telephone
Telephone
+47 22 95 81 93
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercebiotech.com/biotech/nykode-sticks-its-neck-out-betting-future-phase-2-cancer-trial-after-losing-genentech-pact

FIERCE BIOTECH
27 Aug 2025
Genentech axes Nykode cancer vaccine deal
Genentech axes Nykode cancer vaccine deal

09 Nov 2024

// FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/surprise-termination-genentech-drops-nykode-partnership-individualized-cancer-vaccine

FIERCE BIOTECH
09 Nov 2024

https://www.globenewswire.com/news-release/2023/06/01/2679929/0/en/Nykode-Therapeutics-Announces-Expansion-of-Clinical-Collaboration-with-Roche-to-Evaluate-VB10-16-in-Combination-with-anti-PD-L1-in-the-next-trial-in-Advanced-Cervical-Cancer.html

GLOBENEWSWIRE
01 Jun 2023

https://www.globenewswire.com/news-release/2023/05/30/2678651/0/en/Nykode-Therapeutics-to-Present-at-Jefferies-Healthcare-Conference.html

GLOBENEWSWIRE
30 May 2023

https://www.globenewswire.com/news-release/2023/04/18/2649342/0/en/Nykode-Therapeutics-announces-positive-final-results-from-its-Phase-2-trial-of-VB10-16-in-combination-with-PD-L1-inhibitor-atezolizumab-in-advanced-cervical-cancer.html

GLOBENEWSWIRE
18 Apr 2023

https://www.globenewswire.com/news-release/2023/02/22/2613021/0/en/Nykode-Therapeutics-to-announce-financial-results-for-the-fourth-quarter-2022-and-host-webcast-presentation-on-February-28-2023.html

GLOBENEWSWIRE
22 Feb 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty